» Articles » PMID: 18162341

How to Achieve Sustained and Complete Protein Release from PLGA-based Microparticles?

Overview
Journal Int J Pharm
Specialties Chemistry
Pharmacology
Date 2007 Dec 29
PMID 18162341
Citations 71
Authors
Affiliations
Soon will be listed here.
Abstract

One of the most challenging tasks in the delivery of therapeutic proteins from PLGA-based microparticles is the sustained and complete release of the protein in its native form. The mechanisms responsible for incomplete protein release from these devices are numerous and complex; the beneficial effect of different formulations has often been evaluated in vitro. Strategies employed for overcoming protein destabilization during the release step are reviewed in this paper. Proteins have been protected in the deleterious environment by adding stabilizers to the formulation, or by modifying the protein or the polymer. Alternatively, some strategies have aimed at avoiding the formation of the destabilizing environment. As experimental conditions may influence the results from in vitro release studies, we initially report precautions to avoid adverse effects.

Citing Articles

Nanoplatform Based Intranasal Vaccines: Current Progress and Clinical Challenges.

Bai Z, Wan D, Lan T, Hong W, Dong H, Wei Y ACS Nano. 2024; 18(36):24650-24681.

PMID: 39185745 PMC: 11394369. DOI: 10.1021/acsnano.3c10797.


Intra-articular delivery of an indoleamine 2,3-dioxygenase galectin-3 fusion protein for osteoarthritis treatment in male Lewis rats.

Partain B, Bracho-Sanchez E, Farhadi S, Yarmola E, Keselowsky B, Hudalla G Arthritis Res Ther. 2023; 25(1):173.

PMID: 37723593 PMC: 10506271. DOI: 10.1186/s13075-023-03153-0.


Intra-Articular Delivery of an Indoleamine 2,3-Dioxygenase Galectin-3 Fusion Protein for Osteoarthritis Treatment in Male Lewis Rats.

Partain B, Bracho-Sanchez E, Farhadi S, Yarmola E, Keselowsky B, Hudalla G Res Sq. 2023; .

PMID: 37131836 PMC: 10153358. DOI: 10.21203/rs.3.rs-2753443/v1.


A Single Injection with Sustained-Release Microspheres and a Prime-Boost Injection of Bovine Serum Albumin Elicit the Same IgG Antibody Response in Mice.

van der Kooij R, Beukema M, Huckriede A, Zuidema J, Steendam R, Frijlink H Pharmaceutics. 2023; 15(2).

PMID: 36839998 PMC: 9960585. DOI: 10.3390/pharmaceutics15020676.


Preparation of size-tunable sub-200 nm PLGA-based nanoparticles with a wide size range using a microfluidic platform.

Bao Y, Maeki M, Ishida A, Tani H, Tokeshi M PLoS One. 2022; 17(8):e0271050.

PMID: 35925917 PMC: 9352036. DOI: 10.1371/journal.pone.0271050.